Rapid Therapeutic Science Laboratories, Inc. RTSL
We take great care to ensure that the data presented and summarized in this overview for Rapid Therapeutic Science Laboratories, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RTSL
Top Purchases
Top Sells
About RTSL
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.
Insider Transactions at RTSL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
Donal Ray Schmidt Jr. CEO |
SELL
Bona fide gift
|
Indirect |
2,000,000
-3.97%
|
$0
$0.26 P/Share
|
|
Dec 27
2021
|
Sean Paul Berrier > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
2,000,000
-3.97%
|
$0
$0.26 P/Share
|
|
Dec 28
2020
|
Sean Paul Berrier > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-1.18%
|
$0
$0.25 P/Share
|
|
Dec 28
2020
|
Donal Ray Schmidt Jr. CEO |
SELL
Open market or private sale
|
Indirect |
3,666,667
-3.42%
|
$0
$0.28 P/Share
|
|
Dec 22
2020
|
Sean Paul Berrier > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,666,667
-3.42%
|
$0
$0.28 P/Share
|
|
Dec 22
2020
|
Donal Ray Schmidt Jr. CEO |
SELL
Open market or private sale
|
Indirect |
600,000
-1.18%
|
$0
$0.25 P/Share
|
|
Dec 02
2020
|
Donal Ray Schmidt Jr. CEO |
BUY
Other acquisition or disposition
|
Indirect |
54,600,000
+50.0%
|
-
|
|
Dec 02
2020
|
Donal Ray Schmidt Jr. CEO |
SELL
Other acquisition or disposition
|
Indirect |
140,000,000
-100.0%
|
-
|